References
- ADC.sk. Indomethacin. Available at
https://www.adc.sk/databazy/produkty/detail/indometacin-100-berlin-chemie-439509.html (Accessed 14 June 2021). - Alsamman A, Othman M. Preparation and in vitro evaluation of fast release diazepam suppositories for febrile seizures. Asian J Pharm Clin Res. 2017;10:224–230.
- Blumer JL. Principles of drug disposition in the critically ill child. In Fuhrman BP & Zimmerman JJ. Pediatric Critical Care: Saint Louis: Mosby; 2011.
- Constantin IO. Development of misoprostol suppositories for postpartum hemorrhage. Pharmacol Pharm. 2013;4:71–76.
- Council of Europe. European pharmacopoeia 10.0: Softening time determination of lipophilic suppositories (chapter 2.9.22). Strassbourg: EDQM; 2019.
- Gugulothu D, Pathak S, Suryavanshi S, Sharma S, Patravale V. Self-microemulsifiyng suppository formulation of β-artemether. AAPS PharmSciTech. 2010;11:1,179–1,184.
- Hanaee J, Javadzadeh Y, Taftachi S, Farid D, Nokhodchi A. The role of various surfactants on the release of salbutamol from suppositories. Farmaco. 2004; 59: 903–906.
- Hua S. Physiological and pharmaceutical considerations for rectal drug formulations. Front Pharmacol. 2019;10:1,196.
- Melo M, Nunes R, Sarmento B, Neves J. Rectal administration of nanosystems: From drug delivery to diagnostics. Mater Today Chem. 2018;10:128–141.
- Sah M, Saini T. Formulation Development and Release Studies of Indomethacin Suppositories. Indian J Pharm Sci. 2008;70:498–501.
- Szulc-Musiol B, Bulas L, Dolinska B. Effect of Selected Surfactants on Kinetics of Meloxicam Release from Rectal Suppositories. Indian J Pharm Sci. 2019;81:1,115–1,121.